Filing Analysis
Silvaco Group, Inc. announced its financial results for the first fiscal quarter ended March 31, 2026. The company issued a press release and provided supplemental financial information on its corporate website.
Key Facts
- Reporting period: First fiscal quarter ended March 31, 2026.
- Filing date: May 7, 2026.
- The report was filed under Item 2.02 (Results of Operations and Financial Condition).
- Exhibit 99.1 contains the full press release regarding the financial results.
Silvaco Group, Inc. reported the results of its Annual Meeting of Stockholders held on April 22, 2026. All seven director nominees were elected to serve until the 2027 Annual Meeting.
Key Facts
- The Annual Meeting was held on April 22, 2026, with a quorum of approximately 74% of outstanding shares present.
- As of the February 25, 2026 record date, there were 31,423,487 shares of common stock outstanding.
- Seven directors were elected: Cheemin Bo-Linn, Anita Ganti, Anthony Ngai, Katherine S. Ngai-Pesic, Iliya Pesic, Dr. Walden C. Rhines, and Theodore L. Tewksbury III.
- Dr. Walden C. Rhines received the highest number of 'Withhold' votes at 5,708,336, though he was still successfully elected.
Silvaco Group, Inc. has entered into an at-the-market (ATM) sales agreement with Jefferies LLC to sell up to $15.0 million of its common stock. The company may offer and sell shares from time to time at its discretion through the sales agent.
Red Flags
- Potential for shareholder dilution resulting from the issuance of up to $15.0 million in new equity.
Key Facts
- Agreement entered with Jefferies LLC on March 13, 2026.
- Maximum aggregate offering price of $15.0 million in common stock.
- Sales agent compensation is up to 3.0% of gross sales price.
- Sales will be made pursuant to a Form S-3 registration statement effective as of November 21, 2025.
- The company is not obligated to sell any shares and can terminate the offering at any time.
Silvaco Group, Inc. announced its financial results for the fourth quarter and full fiscal year ended December 31, 2025. The disclosure was made via a press release and supplemental financial information posted to the company's website.
Key Facts
- Reporting date of March 12, 2026, for the period ended December 31, 2025.
- The filing includes Item 2.02 (Results of Operations and Financial Condition).
- A press release detailing the financial performance was attached as Exhibit 99.1.
- The company is classified as an emerging growth company.
Silvaco Group, Inc. (SVCO) filed an 8-K disclosing that its Board of Directors approved Amended and Restated Bylaws effective February 13, 2026. The sole purpose of the amendment is to align the stockholder approval threshold for the removal of directors with the Company's Amended and Restated Certificate of Incorporation. This is a routine corporate governance housekeeping filing with no direct financial impact.
Red Flags
- Bylaw change to director removal threshold could potentially serve as an anti-takeover or board entrenchment mechanism — the specific threshold change is not disclosed in the 8-K body and requires review of Exhibit 3.2
Key Facts
- Board approved Amended and Restated Bylaws effective February 13, 2026
- Change aligns the stockholder approval threshold for director removal with the Amended and Restated Certificate of Incorporation
- Filed under Item 5.03 (Amendments to Articles of Incorporation or Bylaws)
- Company is an emerging growth company listed on Nasdaq Global Select Market (ticker: SVCO)
- Signed by Candace Jackson, SVP, General Counsel and Corporate Secretary
- Company is incorporated in Delaware with principal offices in Santa Clara, CA